Prolonged Fasting Reduces Hepatic Fat Content in Patients With Type 2 Diabetes

被引：0
|
作者：
Kahleova, Hana
Belinova, Lenka
Hajek, Milan
Dezortova, Monika
Hill, Martin
Pelikanova, Terezie
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2775-PO
引用
收藏
页码：A691 / A691
页数：1
相关论文
共 50 条
  • [31] Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes
    Moody, Alexander J.
    Molina-Wilkins, Marjorie
    Clarke, Geoffrey D.
    Merovci, Aurora
    Solis-Herrera, Carolina
    Cersosimo, Eugenio
    Chilton, Robert J.
    Iozzo, Patricia
    Gastaldelli, Amalia
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (02): : 426 - 434
  • [32] Hepatic Lipid Content Associates with Fasting and Prandial Glucagon Secretion in Recent-Onset Type 2 Diabetes
    Huttasch, Maximilian
    Kahl, Sabine
    Mori, Tim
    Heilmann, Geronimo
    Trinks, Nina
    Schon, Martin
    Giannakogeorgou, Anna
    Trenkamp, Sandra
    Kupriyanova, Yuliya
    Schrauwen-Hinderling, Vera
    Albrechtsen, Nicolai J. Wewer
    Burkart, Volker
    Wagner, Robert
    The, Michael Roden For
    [J]. DIABETES, 2024, 73
  • [33] Hepatic content in fat is linked to an improvement of the synthesis of cholesterol in type 2 diabetic patients
    Petit, J. M.
    Guiu, B.
    Brindisi, M. C.
    Duvillard, L.
    Bouillet, B.
    Rollot, F.
    Jooste, V.
    Verier, A. C.
    Crevisy, E.
    Athias, A.
    Habchi, M.
    Hilton, P.
    Cercueil, J. P.
    Verges, B.
    [J]. DIABETES & METABOLISM, 2012, 38 : A29 - A29
  • [34] Metabolic determinants of hepatic fat content in type 2 DM
    McKolanis, T
    Crisan, V
    Hegazi, R
    Kelley, DE
    [J]. DIABETES, 2001, 50 : A328 - A328
  • [35] The effect of topiramate on hepatic fat content in obese subjects with drug-naive type 2 diabetes
    Lonn, L
    Brandberg, J
    Vercruysse, F
    Kumar, A
    Fitchet, M
    Sjostrom, L
    Stenlof, K
    [J]. OBESITY RESEARCH, 2004, 12 : A45 - A46
  • [36] Effects of Combined Exenatide and Thiazolidinedione Therapy on Hepatic Fat Content and Plasma Adiponectin in Type 2 Diabetes
    Sathyanarayana, Padma
    Jogi, Medhavi
    Muthupillai, Raja
    Samson, Susan
    Bajaj, Mandeep
    [J]. DIABETES, 2010, 59 : A105 - A105
  • [37] Intermittent Fasting for Patients with Type 2 Diabetes mellitus
    Pavlicek, Vojtech
    [J]. DIABETOLOGIE, 2023, 20 (1): : 154 - 155
  • [38] Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
    Kato, Hiroyuki
    Nagai, Yoshio
    Ohta, Akio
    Tenjin, Ayumi
    Nakamura, Yuta
    Tsukiyama, Hidekazu
    Sasaki, Yosuke
    Fukuda, Hisashi
    Ohshige, Toshihiko
    Terashima, Yuko
    Sada, Yukiyoshi
    Kondo, Akihiko
    Sasaoka, Toshiyasu
    Tanaka, Yasushi
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (01) : 199 - 205
  • [39] Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India
    Ghosh, Amerta
    Dutta, Koel
    Bhatt, Surya Prakash
    Gupta, Ritesh
    Tyagi, Kanika
    Ansari, Irshad Ahmad
    Venugopal, Vasantha Kumar
    Mahajan, Harsh
    Pandey, Ravindra Mohan
    Pandey, Shivam
    Misra, Anoop
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (06): : E2267 - E2275
  • [40] Reduced intra-hepatic fat content is associated with increased lipid oxidation in patients with type 1 diabetes
    Perseghin, G
    Lattuada, G
    De Cobelli, E
    Esposito, A
    Scifo, P
    Maffi, P
    Canu, T
    De Taddeo, E
    Secchi, A
    Del Maschio, A
    Luzi, L
    [J]. DIABETOLOGIA, 2005, 48 : A59 - A60
12345